With more than $270 billion in commitments to date, a new wave of pharmaceutical manufacturing is slated to hit the US. At least, that’s what the industry is trying to project. Take Johnson & ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

The benefits of drug warranties extend beyond risk management. They can also serve as market differentiators in crowded ...

The $91 million expansion near I-77 and Farrow Road has already surpassed the hiring expectations of 100 jobs, the ...

The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...

Sun Pharma bagged eight observations from the US-based regulatory agency US FDA, following an observation at its Halol plant ...